Change at the RBI & more... - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Change at the RBI & more...

Sep 2, 2008

Subbarao to replace Dr. Reddy
Contrary to popular expectations, the Prime Minister has appointed Finance Secretary D. Subbarao as the next governor of the central bank, replacing Dr. Y. V Reddy. At a time when the economy is fighting the highest inflation since 1992, it was expected that the government may extend Dr. Reddy's term because of his decade-long experience at the RBI. Mr. Subbarao will serve for three years, replacing Dr. Reddy whose term ends on September 5. Meanwhile, in a recent interview to Bloomberg Mr. Subbarao was quoted saying, "I can't say firmly that inflation has peaked because it will depend on a number of factors including global factors which are beyond our control". He also cited further rises in interest rates as the 'obvious solution'. Thus Mr. Subbarao may have to follow Dr. Reddy's four-year-old policy of raising borrowing costs as inflation has shown few signs of easing. India's central bank, which prepares monetary policy in consultation with the Finance Ministry will pull out all stops to check prices ahead of elections due by May 2009. During his tenure Dr. Reddy has done a brilliant job of keeping growth and monetary stability well balanced and at the same time safeguarded the Indian banking sector from the global financial crisis. Dr. Reddy has altogether increased the repo rate by 3% since October 2004 to prevent the second-fastest growing economy after China from overheating. He also raised the proportion of CRR that banks need to set aside by 4% since December 2006 to check money supply from stoking inflation. His diligence in efficient governance of the banking and financial sector has been acknowledged the world over. All in all, Mr. Subbarao has very large shoes to fill in.

  • Also read - Monetary Policy: RBI doesn't give up

    Fending off the 'Olympics curse'
    The Olympics have come and gone and while China put up a spectacular show both in the organisation of the event and the competition itself, the limelight has now shifted to the state of the Chinese economy. An interesting fact reported by Morgan Stanley is that 10 of the 11 Summer Olympics host nations (dating back from 1956) analyzed by the firm saw growth and investment slump in the year following the games; the only exception being the US in 1996. Will China be successful in breaking this 'curse'? Infact, key data released with respect to the Chinese economy has not been very enthusing. China's growth slowed down to 10.1% during the second quarter as against 12.6% in the corresponding period last year.

    The Chinese authorities seem determined to reverse this trend. The government has started easing lending restrictions and is contemplating doling out a fiscal stimulus package of US$ 58 bn. Tax cuts are also on the agenda. Bloomberg states, "China has tripled railway spending this year to 300 bn yuan. The current five-year plan, which runs through 2010, calls for investing almost 4.8 trillion yuan on power stations, waterways, roads and other infrastructure projects; more than the combined output of Taiwan, Thailand and Vietnam. Reconstruction after May's Sichuan earthquake could cost another 1 trillion yuan".

    The Asian economies are already feeling the effects of the slowdown in the US and Europe. A Chinese slowdown will only worsen matters further. Hence, China's spending on infrastructure is critical for the Asian nations to enable them to brave the rough weather.

    The link between Olympics and pharma
    What has the Chinese Olympics got to do with Indian pharma companies? The link between the two is raw materials. India at present imports huge quantities of intermediates from China, which the former uses for the manufacture of APIs, which in turn are used in making finished dosages. In a bid to keep pollution under check before and during Olympics, China had shut down many factories which were major pollutants. A host of intermediates manufacturers were among those who were asked to shut down production.

    As a result, other producers hiked prices and this has impacted Indian pharma companies in the form of higher raw material costs. Higher intermediate prices pushing up raw material costs had hampered domestic companies last year as well. However, the sharp appreciation of the rupee against the dollar helped them cushion that blow. This year the scenario is different as the rupee has been depreciating and the high cost of imports do not seem to be abating. While this problem is expected to pressurise pharma companies for the rest of the year, things should start looking up from the start of next year once the production in China scales up.


  • Equitymaster requests your view! Post a comment on "Change at the RBI & more...". Click here!

      

    More Views on News

    What Do the Charts Say About Buying Smallcaps Now? (Fast Profits Daily)

    Sep 18, 2020

    Everyone seems to be excited about buying smallcaps now...but is it the right thing to do? What do the charts tell us? Find out in this video...

    Sundaram Bluechip Fund: Will Hold the Stable Horses (Outside View)

    Sep 18, 2020

    PersonalFn briefly outlines the newly launched NFO note HSBC Corporate Bond Fund.

    Wait! Don't Chase Smallcaps Now (Profit Hunter)

    Sep 18, 2020

    Let the markets take a breather before you jump in.

    How Much Money Do You Need to Be a Professional Trader? (Fast Profits Daily)

    Sep 17, 2020

    In this video I'll answer a question I get asked often: How much capital do I really need to trade the markets for a living? Let's find out...

    A Contrarian View on Whether You Should Load Up on Small Caps podcast (Views On News)

    Sep 17, 2020

    Rahul Shah discusses whether the SEBI circular is the perfect time to start investing in good quality small caps

    More Views on News

    Most Popular

    How the 8-Year Cycle Can Help Identify Multibaggers (Fast Profits Daily)

    Sep 11, 2020

    This is how you can apply the greed and fear cycle in the market to pick stocks.

    I Recommended this Stock over Page Industries because it's Relevant to Doubling Your Income (Profit Hunter)

    Sep 7, 2020

    Things are not often what they seem in the market and how you can take advantage of this.

    The NASDAQ Whale Could Harm Your Portfolio (Fast Profits Daily)

    Sep 7, 2020

    The discovery of Softbank pushing up prices on the NASDAQ will cause volatility in the market. Stay alert!

    This Could Be the Best September for Auto Stocks (Profit Hunter)

    Sep 11, 2020

    Here's why I think this month could be a great for auto stocks.

    More

    Covid-19 Proof
    Multibagger Stocks

    Covid19 Proof Multibaggers
    Get this special report, authored by Equitymaster's top analysts now!
    We will never sell or rent your email id.
    Please read our Terms

    S&P BSE SENSEX


    Sep 18, 2020 03:37 PM

    MARKET STATS